Newsfeeds - Spark Newswire

1 minute read

Gritstone Bio Cash, Cash Equivalents, Marketable Securities And Restricted Cash Were $185.2M As Of December 31, 2022, Compared To $223.5M As Of December 31, 2021

Today, 1:42 PM

Full Year 2022 Financial Results Cash, cash equivalents, marketable securities and restricted cash were $185.2 million as of December 31, 2022, compared to $223.5 million as of December 31,

GRTS

10 minute read

Earnings

Earnings Scheduled For March 9, 2023

By Benzinga Insights

Today, 1:42 PM

Companies Reporting Before The Bell • Aurora Mobile (NASDAQ:JG) is expected to report earnings for its fourth quarter.

ACHR

1 minute read

Gritstone bio And The National Cancer Institute Establish Clinical Trial Agreement To Evaluate A Neoantigen Cell Therapy-Vaccine Combination

By Bill Haddad

Today, 1:42 PM

Under the terms of the agreement, NCI will identify patients with metastatic cancer that are eligible for adoptive cell transfer based on the presence of a G12V or G12D KRAS mutation (KRASmut). Gritstone will provide the

GRTS

3 minute read

Why Planet Labs Shares Are Trading Higher; Here Are 28 Stocks Moving Premarket

By Lisa Levin

Today, 1:42 PM

Gainers Scopus BioPharma Inc. (NASDAQ: SCPS) shares rose 74.7% to $0.4104 in pre-market trading after declining 4% on Wednesday.

ABCL

5 minute read

Why OpGen Shares Are Trading Higher By 220%? Here Are 64 Stocks Moving In Tuesday’s Mid-Day Session

By Lisa Levin

Today, 1:42 PM

Gainers OpGen, Inc. (NASDAQ: OPGN) shares surged 220% to $0.3994 after the company announced topline data from its Unyvero urinary tract infections (UTI) clinical trial.

ACMR

3 minute read

Why G Medical Innovations Shares Are Trading Lower By 35%; Here Are 25 Stocks Moving Premarket

By Lisa Levin

Today, 1:42 PM

Gainers EUDA Health Holdings Limited (NASDAQ: EUDA) shares rose 88.1% to $8.40 in pre-market trading after merger completed with 8i Acquisition SPAC last week.

AEI

1 minute read

Gritstone bio Shares Jump After Updated Overall Survival Data From Colorectal Cancer Candidate

By Vandana Singh

Today, 1:42 PM

Gritstone bio Inc (NASDAQ:GRTS) announced updated overall survival (OS) results from its Phase 1/2 study evaluating GRANITE, an individualized vaccine-based immunotherapy…

GRTS

1 minute read

HC Wainwright & Co. Maintains Buy on Gritstone Bio, Lowers Price Target to $7

By Benzinga Newsdesk

Today, 1:42 PM

HC Wainwright & Co. analyst Sean Lee maintains Gritstone Bio (NASDAQ:GRTS) with a Buy and lowers the price target from $12 to $7.

GRTS

1 minute read

Gritstone Oncology Q3 EPS $(0.35) Up From $(0.36) YoY

By Benzinga Newsdesk

Today, 1:42 PM

Gritstone Oncology (NASDAQ:GRTS) reported quarterly losses of $(0.35) per share. This is a 2.78 percent increase over losses of $(0.36) per share from the same period last year.

GRTS

5 minute read

Why Sonnet BioTherapeutics Shares Surged Over 66%; Here Are 63 Biggest Movers From Yesterday

By Lisa Levin

Today, 1:42 PM

Gainers Sonnet BioTherapeutics Holdings, Inc. (NASDAQ: SONN) climbed 66.4% to close at $1.93 on Monday after the company announced an agreement with Janssen for the evaluation of three Sonnet product candidates.

ACOR